These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9723304)
21. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program. Mueller EA; Kovarik JM; Pittrow D Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246 [No Abstract] [Full Text] [Related]
22. Experience with neoral cyclosporine through the oral route in liver transplantation. Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580 [No Abstract] [Full Text] [Related]
23. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472 [No Abstract] [Full Text] [Related]
24. Area under the concentration curve values in pediatric liver transplant recipients on cyclosporin microemulsion formulation. Dunn SP; Kulinsky A; Falkenstein K; Pierson A; Chang CT; Cooney GF Transplant Proc; 1998 Aug; 30(5):1678-9. PubMed ID: 9723240 [No Abstract] [Full Text] [Related]
25. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine. Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223 [No Abstract] [Full Text] [Related]
27. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient. Falkenstein K; Dunn S Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354 [No Abstract] [Full Text] [Related]
28. Low incidence of acute cellular rejection in liver transplantation with Neoral. Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307 [No Abstract] [Full Text] [Related]
29. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group. Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297 [No Abstract] [Full Text] [Related]
30. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Loss GE; Brady L; Grewal HP; Siegel CT; Mead J; Bruce DS; Cronin DC; Woodle ES; Newell KA; Thistlethwaite JR; Millis JM Transplant Proc; 1998 Jun; 30(4):1435-6. PubMed ID: 9636581 [No Abstract] [Full Text] [Related]
31. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients. Kizilisik AT; al-Sebayel M; Ramirez CB Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549 [No Abstract] [Full Text] [Related]
32. Clinical impact of Neoral in thoracic organ transplantation. Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326 [No Abstract] [Full Text] [Related]
33. Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation. Gusmano R; Basile GC; Perfumo F; Ginevri F; Verrina E; Famularo L; Corbetta G Transplant Proc; 1998 Aug; 30(5):1985-7. PubMed ID: 9723362 [No Abstract] [Full Text] [Related]
34. Cyclosporine conversion from conventional to microemulsion formulation: effect on renal concentration ability in stable hepatic transplant recipients. Fernandez-Fresnedo G; Escallada R; Casafont F; Fábrega E; de Cos MA; Rodrigo E; Cobo M; Cotorruelo JG; Pons F; Arias M Transplant Proc; 1997; 29(1-2):547-8. PubMed ID: 9123123 [No Abstract] [Full Text] [Related]
35. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation. Alvarez F; Atkison P; Grant D; Jones A; Kim P; Kneteman N; Laurin L; Martin S; Paradis K; Shapiro J; Smith L; Superina R; Tan A Transplant Proc; 1998 Aug; 30(5):1961. PubMed ID: 9723352 [No Abstract] [Full Text] [Related]
36. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study. Park K; Kim MS; Kim SI; Kim YS; Moon JI Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557 [No Abstract] [Full Text] [Related]
37. Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine. Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S Transplant Proc; 1998 Aug; 30(5):1760-1. PubMed ID: 9723270 [No Abstract] [Full Text] [Related]
39. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation. Schultz KR; Nevill TJ; Toze CL; Corr T; Currie C; Strong DK; Keown PA Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236 [No Abstract] [Full Text] [Related]
40. Neoral in liver transplantation. Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]